Versant Capital Management’s Tandem Diabetes Care TNDM Stock Holding History
Bought
Maintained
Sold
Other funds holding TNDM
SC
FLAM
GKIM
PIM
Versant Capital Management's TNDM Position: Q2 2026 in Review
Versant Capital Management reduced its Tandem Diabetes Care (TNDM) stake by 90% in Q2 2026, selling an estimated $52.5K and leaving 328 shares worth $4.95K. The position accounts for ﹤0.01% of the portfolio, ranked #2434.
Versant Capital Management first reported a position in TNDM in Q1 2019 and has held it in 26 quarters since. The position peaked at $63.9K in Q1 2026. 274 funds tracked by Wall St. Rank hold TNDM as of Q2 2026.
- Versant Capital Management held 328 shares of Tandem Diabetes Care worth $4.95K as of Q2 2026.
- Versant Capital Management sold 3,007 Tandem Diabetes Care shares in Q2 2026, an estimated $52.5K.
- Tandem Diabetes Care made up ﹤0.01% of Versant Capital Management's portfolio in Q2 2026, its #2434 holding.
- Versant Capital Management first reported a position in Tandem Diabetes Care in Q1 2019 and has held it in 26 quarters since.
- Versant Capital Management's Tandem Diabetes Care position peaked at $63.9K in Q1 2026.
- 274 funds tracked by Wall St. Rank held Tandem Diabetes Care as of Q2 2026.
Based on Versant Capital Management's 13F filing for Q2 2026, filed 2 Jul 2026.